Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes

Zurück zum Zitat Spies M, Vogt PM, Herndon DN (2003) Toxic epidermal necrolysis. A case for the burn intensive care unit. Chirurg 74:452–460CrossRefPubMed Spies M, Vogt PM, Herndon DN (2003) Toxic epidermal necrolysis. A case for the burn intensive care unit. Chirurg 74:452–460CrossRefPubMed

Zurück zum Zitat Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92–96CrossRefPubMed Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92–96CrossRefPubMed

Zurück zum Zitat Arndt KA (1970) The sign of Pyotr Vasilyewich Nikolsky. N Engl J Med 282:1154–1155PubMed Arndt KA (1970) The sign of Pyotr Vasilyewich Nikolsky. N Engl J Med 282:1154–1155PubMed

Zurück zum Zitat Assier H, Bastuji-Garin S, Revuz J, Roujeau JC (1995) Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 131:539–543CrossRefPubMed Assier H, Bastuji-Garin S, Revuz J, Roujeau JC (1995) Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 131:539–543CrossRefPubMed

Zurück zum Zitat Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf E (1996) Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 135:6–11CrossRefPubMed Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf E (1996) Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 135:6–11CrossRefPubMed

Zurück zum Zitat Lyell A (1956) Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68:355–361CrossRefPubMed Lyell A (1956) Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68:355–361CrossRefPubMed

Zurück zum Zitat Iwatsuki K, Yamasaki O, Morizane S, Oono T (2006) Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 42:203–214CrossRefPubMed Iwatsuki K, Yamasaki O, Morizane S, Oono T (2006) Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 42:203–214CrossRefPubMed

Zurück zum Zitat Mutasim DF (2003) Autoimmune bullous dermatoses in the elderly: diagnosis and management. Drugs Aging 20:663–681CrossRefPubMed Mutasim DF (2003) Autoimmune bullous dermatoses in the elderly: diagnosis and management. Drugs Aging 20:663–681CrossRefPubMed

Zurück zum Zitat Mockenhaupt M, Norgauer J (2002) Cutaneous adverse drug reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergy Clin Immunol Int 14:143–150CrossRef Mockenhaupt M, Norgauer J (2002) Cutaneous adverse drug reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergy Clin Immunol Int 14:143–150CrossRef

Zurück zum Zitat Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, Holländer N, Bruppacher R, Schöpf E (1996) Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson Syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry. J Clin Epidemiol 49:769–777CrossRefPubMed Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, Holländer N, Bruppacher R, Schöpf E (1996) Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson Syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry. J Clin Epidemiol 49:769–777CrossRefPubMed

Zurück zum Zitat Mockenhaupt M, Idzko M, Grosber M, Schöpf E, Norgauer J (2005) Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol 125:700–703CrossRef Mockenhaupt M, Idzko M, Grosber M, Schöpf E, Norgauer J (2005) Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol 125:700–703CrossRef

Zurück zum Zitat Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115:149–153CrossRefPubMed Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115:149–153CrossRefPubMed

Zurück zum Zitat Dorafshar AH, Dickie SR, Cohn AB, Aycock JK, O′Connor A, Tung A, Gottlieb LJ (2008) Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach. Plast Reconstr Surg 122:154–160CrossRefPubMed Dorafshar AH, Dickie SR, Cohn AB, Aycock JK, O′Connor A, Tung A, Gottlieb LJ (2008) Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach. Plast Reconstr Surg 122:154–160CrossRefPubMed

Zurück zum Zitat Guegan S, Bastuji-Garin S, Pszepczynska-Guigne E, Roujeau JC, Revuz J (2006) Performance of the SCORTEN during the first 5 days of hospitalization to predict the prognosis of epidermal necrolyse. J Invest Dermatol 126:272–276CrossRefPubMed Guegan S, Bastuji-Garin S, Pszepczynska-Guigne E, Roujeau JC, Revuz J (2006) Performance of the SCORTEN during the first 5 days of hospitalization to predict the prognosis of epidermal necrolyse. J Invest Dermatol 126:272–276CrossRefPubMed

Zurück zum Zitat Vaishampayan SS, Das AL, Verma R (2008) SCORTEN: does it need modification? Indian J Dermatol Venereol Leprol 74:35–37CrossRefPubMed Vaishampayan SS, Das AL, Verma R (2008) SCORTEN: does it need modification? Indian J Dermatol Venereol Leprol 74:35–37CrossRefPubMed

Zurück zum Zitat Hague JS, Goulding JM, Long TM, Gee BC (2007) Respiratory involvement in toxic epidermal necrolysis portends a poor prognosis that may not be reflected in SCORTEN. Br J Dermatol 157:1294–1296CrossRefPubMed Hague JS, Goulding JM, Long TM, Gee BC (2007) Respiratory involvement in toxic epidermal necrolysis portends a poor prognosis that may not be reflected in SCORTEN. Br J Dermatol 157:1294–1296CrossRefPubMed

Zurück zum Zitat Patel GK, Finlay AY (2003) Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 4:165–175CrossRefPubMed Patel GK, Finlay AY (2003) Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 4:165–175CrossRefPubMed

Zurück zum Zitat Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128:35–44CrossRefPubMed Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128:35–44CrossRefPubMed

Zurück zum Zitat Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC, EuroSCAR Study Group (2008) Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58:25–32CrossRefPubMed Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC, EuroSCAR Study Group (2008) Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58:25–32CrossRefPubMed

Zurück zum Zitat Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P (2009) Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics 123:e297–e304CrossRefPubMed Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P (2009) Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics 123:e297–e304CrossRefPubMed

Zurück zum Zitat Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens–Johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343–1350 Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens–Johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343–1350

Zurück zum Zitat Paquet P, Pierard GE (2007) Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review). Int J Mol Med 19:3–10PubMed Paquet P, Pierard GE (2007) Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review). Int J Mol Med 19:3–10PubMed

Zurück zum Zitat Khalili B, Bahna SL (2006) Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol 97:272–280PubMedCrossRef Khalili B, Bahna SL (2006) Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol 97:272–280PubMedCrossRef

Zurück zum Zitat Abe R (2008) Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. J Dermatol Sci 52:151–159CrossRefPubMed Abe R (2008) Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. J Dermatol Sci 52:151–159CrossRefPubMed

Zurück zum Zitat Chung WH, Hung SI, Chen YT (2007) Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 7:317–323CrossRefPubMed Chung WH, Hung SI, Chen YT (2007) Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 7:317–323CrossRefPubMed

Zurück zum Zitat Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M, RegiSCAR study Group (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18:99–107CrossRefPubMed Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M, RegiSCAR study Group (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18:99–107CrossRefPubMed

Zurück zum Zitat Goyal S, Gupta P, Ryanl CM, Kazlas M, Noviski N, Sheridan RL (2009) Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations. J Burn Care Res 30:437–439CrossRefPubMed Goyal S, Gupta P, Ryanl CM, Kazlas M, Noviski N, Sheridan RL (2009) Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations. J Burn Care Res 30:437–439CrossRefPubMed

Zurück zum Zitat Hughey LC (2007) Fever and erythema in the emergency room. Semin Cutan Med Surg 26:133–138CrossRefPubMed Hughey LC (2007) Fever and erythema in the emergency room. Semin Cutan Med Surg 26:133–138CrossRefPubMed

Zurück zum Zitat McGee E, Munster A (1998) Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg 102:118 McGee E, Munster A (1998) Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg 102:118

Zurück zum Zitat Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Study Group (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377CrossRefPubMed Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Study Group (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377CrossRefPubMed

Zurück zum Zitat Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60CrossRefPubMed

Zurück zum Zitat Schummer W (2009) Central venous pressure validity, informative value and correct measurement. Anaesthesist 58:499–505CrossRefPubMed Schummer W (2009) Central venous pressure validity, informative value and correct measurement. Anaesthesist 58:499–505CrossRefPubMed

Zurück zum Zitat Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688CrossRefPubMed Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688CrossRefPubMed

Zurück zum Zitat Pruitt BN Jr (1987) Burn treatment for the unburned. JAMA 257:2207–2208CrossRefPubMed Pruitt BN Jr (1987) Burn treatment for the unburned. JAMA 257:2207–2208CrossRefPubMed

Zurück zum Zitat Oda J, Yamashita K, Inoue T, Harunari N, Ode Y, Mega K, Aoki Y, Noborio M, Ueyama M (2006) Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns. Burns 32:151–154CrossRefPubMed Oda J, Yamashita K, Inoue T, Harunari N, Ode Y, Mega K, Aoki Y, Noborio M, Ueyama M (2006) Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns. Burns 32:151–154CrossRefPubMed

Zurück zum Zitat Daugherty EL, Liang Hongyan, Taichman D, Hansen-Flaschen J, Fuchs BD (2007) Abdominal compartment syndrome is common in medical intensive care unit patients receiving large-volume resuscitation. J Intensive Care Med 22:294–299CrossRefPubMed Daugherty EL, Liang Hongyan, Taichman D, Hansen-Flaschen J, Fuchs BD (2007) Abdominal compartment syndrome is common in medical intensive care unit patients receiving large-volume resuscitation. J Intensive Care Med 22:294–299CrossRefPubMed

Zurück zum Zitat Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH (2008) Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 14:508–514CrossRefPubMed Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH (2008) Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 14:508–514CrossRefPubMed

Zurück zum Zitat Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH (2008) Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 52:200–207CrossRefPubMed Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH (2008) Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 52:200–207CrossRefPubMed

Zurück zum Zitat Roujeau JC, Chosidow O, Saiag P, Guillauma JC (1990) Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 23:1039–1058CrossRefPubMed Roujeau JC, Chosidow O, Saiag P, Guillauma JC (1990) Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 23:1039–1058CrossRefPubMed

Zurück zum Zitat Gandhi M, Kowal-Vern A, An G, Hanumadass M (2008) Blister fluid composition in a pediatric patient with toxic epidermal necrolysis. J Burn Care Res 29:671–675CrossRefPubMed Gandhi M, Kowal-Vern A, An G, Hanumadass M (2008) Blister fluid composition in a pediatric patient with toxic epidermal necrolysis. J Burn Care Res 29:671–675CrossRefPubMed

Zurück zum Zitat Lehnhardt M, Jafari HJ, Druecke D, Steinstraesser L, Steinau HU, Klatte W, Schwake R, Homann HH (2005) A qualitative and quantitative analysis of protein loss in human burn wounds. Burns 31:159–167CrossRefPubMed Lehnhardt M, Jafari HJ, Druecke D, Steinstraesser L, Steinau HU, Klatte W, Schwake R, Homann HH (2005) A qualitative and quantitative analysis of protein loss in human burn wounds. Burns 31:159–167CrossRefPubMed

Zurück zum Zitat Boldt J, Papsdorf M (2008) Fluid management in burn patients: results from a European survey—more questions than answers. Burns 34:323–328CrossRef Boldt J, Papsdorf M (2008) Fluid management in burn patients: results from a European survey—more questions than answers. Burns 34:323–328CrossRef

Zurück zum Zitat Venkatesh B, Gough J, Ralston DR, Muller M, Pegg S (2004) Protein losing enteropathy in critically ill adult patients with burns: a preliminary report. Intensive Care Med 30:162–166CrossRefPubMed Venkatesh B, Gough J, Ralston DR, Muller M, Pegg S (2004) Protein losing enteropathy in critically ill adult patients with burns: a preliminary report. Intensive Care Med 30:162–166CrossRefPubMed

Zurück zum Zitat Perel P, Roberts I (2007) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 17:CD000567 Perel P, Roberts I (2007) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 17:CD000567

Zurück zum Zitat Spirt MJ (2004) Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 26:197–213CrossRefPubMed Spirt MJ (2004) Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 26:197–213CrossRefPubMed

Zurück zum Zitat Kvasnicka J, Rezac J, Svejda J, Duchkova H, Kaze F, Zalud P, Richter J (1979) Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell’s syndrome). Br J Dermatol 100:551–558CrossRefPubMed Kvasnicka J, Rezac J, Svejda J, Duchkova H, Kaze F, Zalud P, Richter J (1979) Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell’s syndrome). Br J Dermatol 100:551–558CrossRefPubMed

Zurück zum Zitat Pottier P, Hardouin JB, Lejeune S, Jolliet P, Gillet B, Planchon B (2009) Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies. Thromb Res 124:468–476CrossRefPubMed Pottier P, Hardouin JB, Lejeune S, Jolliet P, Gillet B, Planchon B (2009) Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies. Thromb Res 124:468–476CrossRefPubMed

Zurück zum Zitat Ballard J, Edelman L, Saffle J, Sheridan R, Kagan R, Bracco D, Cancio L, Cairns B, Baker R, Fillari B, Wibbenmeyer L, Voight D, Palmieri T, Greenhalgh D, Kemalyan N, Caruso D, Multicenter Trials Group, American Burn Association (2008) Positive fungal cultures in burn patients: a multicenter review. J Burn Care Res 29:213–221PubMed Ballard J, Edelman L, Saffle J, Sheridan R, Kagan R, Bracco D, Cancio L, Cairns B, Baker R, Fillari B, Wibbenmeyer L, Voight D, Palmieri T, Greenhalgh D, Kemalyan N, Caruso D, Multicenter Trials Group, American Burn Association (2008) Positive fungal cultures in burn patients: a multicenter review. J Burn Care Res 29:213–221PubMed

Zurück zum Zitat Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT (1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204:503–512CrossRefPubMed Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT (1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204:503–512CrossRefPubMed

Zurück zum Zitat Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol 58:33–40CrossRefPubMed Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol 58:33–40CrossRefPubMed

Zurück zum Zitat Guibal F, Bastuji-Garin S, Chosidow O, Saiag P, Revuz J, Roujeau JC (1995) Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 131:669–672CrossRefPubMed Guibal F, Bastuji-Garin S, Chosidow O, Saiag P, Revuz J, Roujeau JC (1995) Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 131:669–672CrossRefPubMed

Zurück zum Zitat Bahna SL, Khalili B (2007) New concepts in the management of adverse drug reactions. Allergy Asthma Proc 28:517–524CrossRefPubMed Bahna SL, Khalili B (2007) New concepts in the management of adverse drug reactions. Allergy Asthma Proc 28:517–524CrossRefPubMed

Zurück zum Zitat Fernandez AP, Kerdel FA (2007) The use of i.v. IG therapy in dermatology. Dermatol Ther 20:288–305CrossRefPubMed Fernandez AP, Kerdel FA (2007) The use of i.v. IG therapy in dermatology. Dermatol Ther 20:288–305CrossRefPubMed

Zurück zum Zitat Bachot N, Revuz J, Roujeau JC (2003) Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 139:33–36CrossRefPubMed Bachot N, Revuz J, Roujeau JC (2003) Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 139:33–36CrossRefPubMed

Zurück zum Zitat Mittmann N, Chan B, Knowles S, Cosentino L, Shear N (2006) Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 7:359–368CrossRefPubMed Mittmann N, Chan B, Knowles S, Cosentino L, Shear N (2006) Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 7:359–368CrossRefPubMed

Zurück zum Zitat Faye O, Roujeau JC (2005) Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date. Drugs 65:2085–2090CrossRefPubMed Faye O, Roujeau JC (2005) Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date. Drugs 65:2085–2090CrossRefPubMed

Zurück zum Zitat Whitaker IS, Prowse S, Potokar TS (2008) A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon. Ann Plast Surg 60:333–337CrossRefPubMed Whitaker IS, Prowse S, Potokar TS (2008) A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon. Ann Plast Surg 60:333–337CrossRefPubMed

Zurück zum Zitat Boorboor P, Vogt PM, Bechara FG, Alkandari Q, Aust M, Gohritz A, Spies M (2008) Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. Burns 34:487–492CrossRefPubMed Boorboor P, Vogt PM, Bechara FG, Alkandari Q, Aust M, Gohritz A, Spies M (2008) Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. Burns 34:487–492CrossRefPubMed

Zurück zum Zitat Dalli RL, Kumar R, Kennedy P, Maitz P, Lee S, Johnson R (2007) Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management. ANZ J Surg 77:671–676CrossRefPubMed Dalli RL, Kumar R, Kennedy P, Maitz P, Lee S, Johnson R (2007) Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management. ANZ J Surg 77:671–676CrossRefPubMed

Zurück zum Zitat Ryan DW (1995) The fluidised bed. Intensive Care Med 21:270–276CrossRefPubMed Ryan DW (1995) The fluidised bed. Intensive Care Med 21:270–276CrossRefPubMed

Zurück zum Zitat Hsiao CT, Lin LJ, Shiao CJ, Hsiao KY, Chen IC (2008) Hemorrhagic bullae are not only skin deep. Am J Emerg Med 26:316–319CrossRefPubMed Hsiao CT, Lin LJ, Shiao CJ, Hsiao KY, Chen IC (2008) Hemorrhagic bullae are not only skin deep. Am J Emerg Med 26:316–319CrossRefPubMed

Zurück zum Zitat Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC (1997) Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 23:1237–1244CrossRefPubMed Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC (1997) Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 23:1237–1244CrossRefPubMed

Zurück zum Zitat Jäckel R, Fuchs M, Raff T, Wiedemann B (2002) Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract. A case report. Anaesthesist 51:815–819CrossRefPubMed Jäckel R, Fuchs M, Raff T, Wiedemann B (2002) Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract. A case report. Anaesthesist 51:815–819CrossRefPubMed

Zurück zum Zitat Fine JD, Johnson LB, Weiner M, Suchindran C (2007) Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry. Laryngoscope 117:1652–1660CrossRefPubMed Fine JD, Johnson LB, Weiner M, Suchindran C (2007) Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry. Laryngoscope 117:1652–1660CrossRefPubMed

Zurück zum Zitat Windfuhr JP, Schloendorff G, Baburi D, Kremer B (2008) Life-threatening posttonsillectomy hemorrhage. Laryngoscope 118:1389–1394CrossRefPubMed Windfuhr JP, Schloendorff G, Baburi D, Kremer B (2008) Life-threatening posttonsillectomy hemorrhage. Laryngoscope 118:1389–1394CrossRefPubMed

Zurück zum Zitat Riazi S, Karkouti K, Heggie J (2006) Case report: management of life-threatening oropharyngeal bleeding with recombinant factor VIIa. Can J Anaesth 53:881–884CrossRefPubMed Riazi S, Karkouti K, Heggie J (2006) Case report: management of life-threatening oropharyngeal bleeding with recombinant factor VIIa. Can J Anaesth 53:881–884CrossRefPubMed

Zurück zum Zitat Kluger E (1998) Fatal outcome in allopurinol hypersensitivity syndrome. Ugeskr Laeger 160:1179–1180PubMed Kluger E (1998) Fatal outcome in allopurinol hypersensitivity syndrome. Ugeskr Laeger 160:1179–1180PubMed

Zurück zum Zitat Garza A, Waldman AJ, Mamel J (2005) A case of toxic epidermal necrolysis with involvement of the GI tract after systemic contrast agent application at cardiac catheterization. Gastrointest Endosc 62:638–642CrossRefPubMed Garza A, Waldman AJ, Mamel J (2005) A case of toxic epidermal necrolysis with involvement of the GI tract after systemic contrast agent application at cardiac catheterization. Gastrointest Endosc 62:638–642CrossRefPubMed

Zurück zum Zitat Krejci V, Hiltebrand LB, Sigurdsson GH (2006) Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 34:1456–1463CrossRefPubMed Krejci V, Hiltebrand LB, Sigurdsson GH (2006) Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 34:1456–1463CrossRefPubMed

Zurück zum Zitat Lamblin V, Favory R, Boulo M, Mathieu D (2006) Microcirculatory alterations induced by sedation in intensive care patients. Effects of midazolam alone and in association with sufentanil. Crit Care 10:R176CrossRefPubMed Lamblin V, Favory R, Boulo M, Mathieu D (2006) Microcirculatory alterations induced by sedation in intensive care patients. Effects of midazolam alone and in association with sufentanil. Crit Care 10:R176CrossRefPubMed

Zurück zum Zitat Gregory DG (2008) The ophthalmologic management of acute Stevens-Johnson syndrome. Ocul Surf 6:87–95PubMed Gregory DG (2008) The ophthalmologic management of acute Stevens-Johnson syndrome. Ocul Surf 6:87–95PubMed

Zurück zum Zitat Lasudry J (2007) The pathology of ocular syndromes caused by toxicity. Bull Soc Belge Ophtalmol 304:155–178PubMed Lasudry J (2007) The pathology of ocular syndromes caused by toxicity. Bull Soc Belge Ophtalmol 304:155–178PubMed

Zurück zum Zitat Chang YS, Huang FC, Tseng SH, Hsu CK, HO CL, Sheu HM (2007) Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26:123–129CrossRefPubMed Chang YS, Huang FC, Tseng SH, Hsu CK, HO CL, Sheu HM (2007) Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26:123–129CrossRefPubMed

Zurück zum Zitat Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC (2000) Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136:323–327CrossRefPubMed Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC (2000) Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136:323–327CrossRefPubMed

Zurück zum Zitat Stern RS (2000) Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 136:410CrossRefPubMed Stern RS (2000) Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 136:410CrossRefPubMed

Zurück zum Zitat Mockenhaupt M (2009) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 7:142–163PubMed Mockenhaupt M (2009) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 7:142–163PubMed

Zurück zum Zitat Poloczek S, Madler C (2000) Transport of intensive care patients. Anaesthesist 49:480–491CrossRefPubMed Poloczek S, Madler C (2000) Transport of intensive care patients. Anaesthesist 49:480–491CrossRefPubMed

Zurück zum Zitat Warren J, Fromm RE Jr, Orr RA, Rotello LC, Horst HM, American College of Critical Care Medicine (2004) Guidelines for the inter- and intrahospital transport of critically ill patients. Crit Care Med 32:256–262CrossRefPubMed Warren J, Fromm RE Jr, Orr RA, Rotello LC, Horst HM, American College of Critical Care Medicine (2004) Guidelines for the inter- and intrahospital transport of critically ill patients. Crit Care Med 32:256–262CrossRefPubMed

Zurück zum Zitat Bork K (2005) Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 152:3–12CrossRefPubMed Bork K (2005) Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 152:3–12CrossRefPubMed

Zurück zum Zitat Holland NJ, Sandhu GS, Ghufoor K, Frosh A (2001) The Foley catheter in the management of epistaxis. Int J Clin Pract 55:14–15PubMed Holland NJ, Sandhu GS, Ghufoor K, Frosh A (2001) The Foley catheter in the management of epistaxis. Int J Clin Pract 55:14–15PubMed

Zurück zum Zitat Danzl D (2002) Hypothermia. Semin Respir Crit Care Med 23:57–68CrossRefPubMed Danzl D (2002) Hypothermia. Semin Respir Crit Care Med 23:57–68CrossRefPubMed